Sector Chart Monopar Therapeutics Inc.

Stocks

MNPR

US61023L2079

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-31 EDT			After hours 19:26:38
108.35 ^USD	-5.50%		99.94	-7.76%

07-22	Monopar Therapeutics Begins Rolling Application for ALXN1840 in Wilson Disease	MT
06-30	Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation For ALXN1840 For The Treatment Of Wilson Disease	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
MONOPAR THERAPEUTICS INC.	726M	-	-	-	-	-
LONZA GROUP AG	48.53B
REVOLUTION MEDICINES, INC.	39.87B	-	-	-	-	-
IQVIA HOLDINGS INC.	38.68B
BEONE MEDICINES AG	35.13B
CELLTRION, INC.	29.79B